Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Mauri

Showing results (11-20 of 134) with videos related to

Pageof 14
Sort By:
Urologic Oncology|September 8, 2005
Inflammatory prostate cancer: an underestimated paraneoplastic clinical manifestationDavide Mauri, George Pentheroudakis, Christos Tolis, et al.
SAGE Open Medical Case Reports|January 25, 2020
A case report of psoriasis flare following immunotherapy: Report of an important entity and literature reviewAnastasia Politi, Dimas Angelos, Davide Mauri, et al.
The Lancet. Oncology|May 16, 2020
Summary of international recommendations in 23 languages for patients with cancer during the COVID-19 pandemicDavide Mauri, Konstantinos Kamposioras, Maria Tolia, et al.
ESMO Open|June 27, 2018
Role of chemotherapy in resectable liver metastases from colorectal cancer: food for thought from pooled evidenceDavide Mauri, Panagiotis Filis, Lampriani Tsali, et al.
Breast Cancer Research and Treatment|December 1, 2020
Predictive role of HER2-status on the effectiveness of endocrine adjuvant treatment in postmenopausal breast cancer patients: a population-based cohort studyAglaia Schiza, Davide Mauri, Irma Fredriksson, et al.
Journal of the National Cancer Institute|September 21, 2006
Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysisDavide Mauri, Nicholas Pavlidis, Nikolaos P Polyzos, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 16, 2011
Industry involvement and baseline assumptions of cost-effectiveness analyses: diagnostic accuracy of the Papanicolaou testNikolaos P Polyzos, Antonis Valachis, Davide Mauri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2012
Financial relationships in economic analyses of targeted therapies in oncologyAntonis Valachis, Nikolaos P Polyzos, Andreas Nearchou, et al.
The American Journal of Gastroenterology|March 18, 2008
Low colorectal cancer screening rates and primary care physicians' behaviorKonstantinos Kamposioras, Davide Mauri, Antonis Valachis, et al.
Gynecologic Oncology|January 12, 2010
Lack of evidence for fracture prevention in early breast cancer bisphosphonate trials: a meta-analysisAntonis Valachis, Nikolaos P Polyzos, Vassilis Georgoulias, et al.
Pageof 14

Showing results (11-20 of 134) with videos related to

Sort By:
Pageof 14
Urologic Oncology|September 8, 2005
Inflammatory prostate cancer: an underestimated paraneoplastic clinical manifestationDavide Mauri, George Pentheroudakis, Christos Tolis, et al.
SAGE Open Medical Case Reports|January 25, 2020
A case report of psoriasis flare following immunotherapy: Report of an important entity and literature reviewAnastasia Politi, Dimas Angelos, Davide Mauri, et al.
The Lancet. Oncology|May 16, 2020
Summary of international recommendations in 23 languages for patients with cancer during the COVID-19 pandemicDavide Mauri, Konstantinos Kamposioras, Maria Tolia, et al.
ESMO Open|June 27, 2018
Role of chemotherapy in resectable liver metastases from colorectal cancer: food for thought from pooled evidenceDavide Mauri, Panagiotis Filis, Lampriani Tsali, et al.
Breast Cancer Research and Treatment|December 1, 2020
Predictive role of HER2-status on the effectiveness of endocrine adjuvant treatment in postmenopausal breast cancer patients: a population-based cohort studyAglaia Schiza, Davide Mauri, Irma Fredriksson, et al.
Journal of the National Cancer Institute|September 21, 2006
Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysisDavide Mauri, Nicholas Pavlidis, Nikolaos P Polyzos, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 16, 2011
Industry involvement and baseline assumptions of cost-effectiveness analyses: diagnostic accuracy of the Papanicolaou testNikolaos P Polyzos, Antonis Valachis, Davide Mauri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2012
Financial relationships in economic analyses of targeted therapies in oncologyAntonis Valachis, Nikolaos P Polyzos, Andreas Nearchou, et al.
The American Journal of Gastroenterology|March 18, 2008
Low colorectal cancer screening rates and primary care physicians' behaviorKonstantinos Kamposioras, Davide Mauri, Antonis Valachis, et al.
Gynecologic Oncology|January 12, 2010
Lack of evidence for fracture prevention in early breast cancer bisphosphonate trials: a meta-analysisAntonis Valachis, Nikolaos P Polyzos, Vassilis Georgoulias, et al.
Pageof 14